{"formats":[{"name":"JSON","format":"json","url":"\/downloads\/2025\/code-json\/32.1-50.2.json"},{"name":"Plain Text","format":"text","url":"\/downloads\/2025\/code-text\/32.1-50.2.txt"},{"name":"XML","format":"xml","url":"\/downloads\/2025\/code-xml\/32.1-50.2.xml"},{"name":"HTML","format":"html","url":"\/downloads\/2025\/code-html\/32.1-50.2.html"}],"law_id":63399,"edition_id":1,"section_id":63399,"structure_id":15563,"section_number":"32.1-50.2","catch_line":"Administration of tuberculin purified protein derivative by nurses; policies and guidelines","history":"2003, c. 515.","full_text":"The Department shall issue policies and guidelines governing the possession and administration of tuberculin purified protein derivative (PPD) by registered nurses and licensed practical nurses pursuant to \u00a7 54.1-3408.","order_by":null,"text":{"0":{"id":231021,"text":"The Department shall issue policies and guidelines governing the possession and administration of tuberculin purified protein derivative (PPD) by registered nurses and licensed practical nurses pursuant to \u00a7 54.1-3408.","type":"section","prefixes":[""],"prefix":"","entire_prefix":"","prefix_anchor":"","level":1}},"ancestry":[{"id":15563,"edition_id":1,"name":"Tuberculosis","identifier":"4","label":"article","depth":3,"order_by":1,"parent_id":13607,"metadata":{},"date_created":"2026-06-26 03:56:22","date_modified":"2026-06-26 03:56:22","permalink":{"id":202123,"object_type":"structure","relational_id":15563,"identifier":"4","token":"32.1\/2\/4","url":"\/32.1\/2\/4\/","edition_id":1,"permalink":0,"preferred":1}},{"id":13607,"edition_id":1,"name":"Disease Prevention and Control","identifier":"2","label":"chapter","depth":2,"order_by":1,"parent_id":12727,"metadata":{},"date_created":"2026-06-26 03:45:22","date_modified":"2026-06-26 03:45:22","permalink":{"id":201743,"object_type":"structure","relational_id":13607,"identifier":"2","token":"32.1\/2","url":"\/32.1\/2\/","edition_id":1,"permalink":0,"preferred":1}},{"id":12727,"edition_id":1,"name":"Health","identifier":"32.1","label":"title","depth":1,"order_by":1,"parent_id":null,"metadata":{},"date_created":"2026-06-26 03:43:50","date_modified":"2026-06-26 03:43:50","permalink":{"id":201099,"object_type":"structure","relational_id":12727,"identifier":"32.1","token":"32.1","url":"\/32.1\/","edition_id":1,"permalink":0,"preferred":1}}],"structure_contents":[{"id":75437,"structure_id":15563,"section_number":"32.1-49","catch_line":"Tuberculosis required to be reported","url":"\/32.1-49\/","token":"32.1\/2\/4\/32.1-49","metadata":false},{"id":86126,"structure_id":15563,"section_number":"32.1-49.1","catch_line":"Definitions","url":"\/32.1-49.1\/","token":"32.1\/2\/4\/32.1-49.1","metadata":false},{"id":84024,"structure_id":15563,"section_number":"32.1-50","catch_line":"Examination of persons suspected of having active tuberculosis disease; reporting; report forms; report schedule; laboratory reports and required samples","url":"\/32.1-50\/","token":"32.1\/2\/4\/32.1-50","metadata":false},{"id":59369,"structure_id":15563,"section_number":"32.1-50.1","catch_line":"Treatment plan; submission of plan and mediation of disagreements; determination of cure","url":"\/32.1-50.1\/","token":"32.1\/2\/4\/32.1-50.1","metadata":false},{"id":63399,"structure_id":15563,"section_number":"32.1-50.2","catch_line":"Administration of tuberculin purified protein derivative by nurses; policies and guidelines","url":"\/32.1-50.2\/","token":"32.1\/2\/4\/32.1-50.2","metadata":false},{"id":65487,"structure_id":15563,"section_number":"32.1-51","catch_line":"Repealed","url":"\/32.1-51\/","token":"32.1\/2\/4\/32.1-51","metadata":false},{"id":60569,"structure_id":15563,"section_number":"32.1-53","catch_line":"Facilities and contracts for treatment of tuberculosis patients","url":"\/32.1-53\/","token":"32.1\/2\/4\/32.1-53","metadata":false},{"id":66945,"structure_id":15563,"section_number":"32.1-54","catch_line":"Commissioner authorized to charge patients for care","url":"\/32.1-54\/","token":"32.1\/2\/4\/32.1-54","metadata":false}],"previous_section":{"id":59369,"structure_id":15563,"section_number":"32.1-50.1","catch_line":"Treatment plan; submission of plan and mediation of disagreements; determination of cure","url":"\/32.1-50.1\/","token":"32.1\/2\/4\/32.1-50.1","metadata":false},"next_section":{"id":65487,"structure_id":15563,"section_number":"32.1-51","catch_line":"Repealed","url":"\/32.1-51\/","token":"32.1\/2\/4\/32.1-51","metadata":false},"metadata":false,"official_url":"https:\/\/law.lis.virginia.gov\/vacode\/32.1-50.2\/","history_text":"<p>This law was first created in 2003. The record of its establishment is cataloged in chapter <a href=\"https:\/\/legacylis.virginia.gov\/cgi-bin\/legp604.exe?031+ful+CHAP0515\">515<\/a> of that year\u2019s edition of \u201cActs of Assembly,\u201d the annual state publication listing all changes made to the Code of Virginia in that year.<\/p>","references":[{"id":77665,"section_number":"54.1-3408","catch_line":"Professional use by practitioners","order_by":null,"url":"\/54.1-3408\/"}],"refers_to":[{"id":77665,"section_number":"54.1-3408","catch_line":"Professional use by practitioners","order_by":null,"url":"\/54.1-3408\/"}],"permalink":{"id":202141,"object_type":"law","relational_id":63399,"identifier":"32.1-50.2","token":"32.1\/2\/4\/32.1-50.2","url":"\/32.1-50.2\/","edition_id":1,"permalink":0,"preferred":1},"url":"\/32.1-50.2\/","token":"32.1\/2\/4\/32.1-50.2","dublin_core":{"Title":"Administration of tuberculin purified protein derivative by nurses; policies and guidelines","Type":"Text","Format":"text\/html","Identifier":"\u00a7 32.1-50.2","Relation":"Code of Virginia"},"html":"\n\t\t\t\t\t\t<section><p>The <span class=\"dictionary\">Department<\/span> shall <span class=\"dictionary\">issue<\/span> policies and guidelines governing the <span class=\"dictionary\">possession<\/span> and administration of tuberculin purified protein derivative (PPD) by registered nurses and licensed practical nurses pursuant to \u00a7&nbsp;<a class=\"law\" title=\"Professional use by practitioners\" href=\"\/54.1-3408\/\">54.1-3408<\/a>.<\/p><\/section>","plain_text":"                                 CODE OF VIRGINIA\n\nADMINISTRATION OF TUBERCULIN PURIFIED PROTEIN DERIVATIVE BY NURSES; POLICIES AND\nGUIDELINES (\u00a7 32.1-50.2)\n\nThe Department shall issue policies and guidelines governing the possession and\nadministration of tuberculin purified protein derivative (PPD) by registered\nnurses and licensed practical nurses pursuant to \u00a7 54.1-3408.\n\nHISTORY: 2003, c. 515.","edition":{"id":1,"name":"2025","slug":"2025","date_created":"2026-06-21 22:39:22","date_modified":"2026-06-21 22:39:22","current":1,"order_by":1,"last_import":null}}